TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Biopharmaceutical and Vaccines Market Report & Forecast 2022-2028

Global and United States Biopharmaceutical and Vaccines Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 05 October 2022
  • Pages :95
  • Formats:
  • Report Code:SMR-7412748
OfferClick for best price

Best Price: $3480

Biopharmaceutical Vaccines Market Size, Share 2022


Market Analysis and Insights: Global Biopharmaceutical Vaccines Market

The global Biopharmaceutical Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical Vaccines market.

Global Biopharmaceutical Vaccines Scope and Market Size

Biopharmaceutical and Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Biopharmaceutical and Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Biopharmaceutical

Vaccine Production

Segment by Application

Pharmaceuticals Industry

Clinical Diagnosis

Scientific Research

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Novartis

Pfizer

Sanofi

Roche

Abbott

Biogen Idec

Regeneron Pharmaceuticals

Alexion Pharmaceuticals

Johnson and Johnson

GlaxoSmithKline

Merck

Lonza

Boehringer Ingelheim

Rentschler

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Biopharmaceutical Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Biopharmaceutical Vaccines, with price, sales, revenue, and global market share of Biopharmaceutical Vaccines from 2019 to 2022.

Chapter 3, the Biopharmaceutical Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biopharmaceutical Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biopharmaceutical Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Biopharmaceutical Vaccines.

Chapter 13, 14, and 15, to describe Biopharmaceutical Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Biopharmaceutical Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Biopharmaceutical and Vaccines Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 95 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Biopharmaceutical and Vaccines Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million) Introduction
1.2 Global Biopharmaceutical and Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Biopharmaceutical and Vaccines Market Size for the Year 2017-2028
1.2.2 Global Biopharmaceutical and Vaccines Market Size for the Year 2017-2028
1.3 Biopharmaceutical and Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Biopharmaceutical and Vaccines in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Biopharmaceutical and Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Biopharmaceutical and Vaccines Market Dynamics
1.4.1 Biopharmaceutical and Vaccines Industry Trends
1.4.2 Biopharmaceutical and Vaccines Market Drivers
1.4.3 Biopharmaceutical and Vaccines Market Challenges
1.4.4 Biopharmaceutical and Vaccines Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Biopharmaceutical and Vaccines by Type
2.1 Biopharmaceutical and Vaccines Market Segment by Type
2.1.1 Biopharmaceutical
2.1.2 Vaccine Production
2.2 Global Biopharmaceutical and Vaccines Market Size by Type (2017, 2022 & 2028)
2.3 Global Biopharmaceutical and Vaccines Market Size by Type (2017-2028)
2.4 United States Biopharmaceutical and Vaccines Market Size by Type (2017, 2022 & 2028)
2.5 United States Biopharmaceutical and Vaccines Market Size by Type (2017-2028)
3 Biopharmaceutical and Vaccines by Application
3.1 Biopharmaceutical and Vaccines Market Segment by Application
3.1.1 Pharmaceuticals Industry
3.1.2 Clinical Diagnosis
3.1.3 Scientific Research
3.1.4 Others
3.2 Global Biopharmaceutical and Vaccines Market Size by Application (2017, 2022 & 2028)
3.3 Global Biopharmaceutical and Vaccines Market Size by Application (2017-2028)
3.4 United States Biopharmaceutical and Vaccines Market Size by Application (2017, 2022 & 2028)
3.5 United States Biopharmaceutical and Vaccines Market Size by Application (2017-2028)
4 Global Biopharmaceutical and Vaccines Competitor Landscape by Company
4.1 Global Biopharmaceutical and Vaccines Market Size by Company
4.1.1 Top Global Biopharmaceutical and Vaccines Companies Ranked by Revenue (2021)
4.1.2 Global Biopharmaceutical and Vaccines Revenue by Player (2017-2022)
4.2 Global Biopharmaceutical and Vaccines Concentration Ratio (CR)
4.2.1 Biopharmaceutical and Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Biopharmaceutical and Vaccines in 2021
4.2.3 Global Biopharmaceutical and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Biopharmaceutical and Vaccines Headquarters, Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million) Type
4.3.1 Global Biopharmaceutical and Vaccines Headquarters and Area Served
4.3.2 Global Biopharmaceutical and Vaccines Companies Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Biopharmaceutical and Vaccines Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Biopharmaceutical and Vaccines Market Size by Company
4.5.1 Top Biopharmaceutical and Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Biopharmaceutical and Vaccines Revenue by Players (2020, 2021 & 2022)
5 Global Biopharmaceutical and Vaccines Market Size by Region
5.1 Global Biopharmaceutical and Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Biopharmaceutical and Vaccines Market Size by Region (2017-2028)
5.2.1 Global Biopharmaceutical and Vaccines Market Size by Region: 2017-2022
5.2.2 Global Biopharmaceutical and Vaccines Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Biopharmaceutical and Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Biopharmaceutical and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Biopharmaceutical and Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Biopharmaceutical and Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Biopharmaceutical and Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Biopharmaceutical and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Biopharmaceutical and Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Biopharmaceutical and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Biopharmaceutical and Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Biopharmaceutical and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Details
7.1.2 Novartis Business Overview
7.1.3 Novartis Biopharmaceutical and Vaccines Introduction
7.1.4 Novartis Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.1.5 Novartis Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Details
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Biopharmaceutical and Vaccines Introduction
7.2.4 Pfizer Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.2.5 Pfizer Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Details
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Biopharmaceutical and Vaccines Introduction
7.3.4 Sanofi Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.3.5 Sanofi Recent Development
7.4 Roche
7.4.1 Roche Company Details
7.4.2 Roche Business Overview
7.4.3 Roche Biopharmaceutical and Vaccines Introduction
7.4.4 Roche Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.4.5 Roche Recent Development
7.5 Abbott
7.5.1 Abbott Company Details
7.5.2 Abbott Business Overview
7.5.3 Abbott Biopharmaceutical and Vaccines Introduction
7.5.4 Abbott Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.5.5 Abbott Recent Development
7.6 Biogen Idec
7.6.1 Biogen Idec Company Details
7.6.2 Biogen Idec Business Overview
7.6.3 Biogen Idec Biopharmaceutical and Vaccines Introduction
7.6.4 Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.6.5 Biogen Idec Recent Development
7.7 Regeneron Pharmaceuticals
7.7.1 Regeneron Pharmaceuticals Company Details
7.7.2 Regeneron Pharmaceuticals Business Overview
7.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Introduction
7.7.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.7.5 Regeneron Pharmaceuticals Recent Development
7.8 Alexion Pharmaceuticals
7.8.1 Alexion Pharmaceuticals Company Details
7.8.2 Alexion Pharmaceuticals Business Overview
7.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Introduction
7.8.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.8.5 Alexion Pharmaceuticals Recent Development
7.9 Johnson and Johnson
7.9.1 Johnson and Johnson Company Details
7.9.2 Johnson and Johnson Business Overview
7.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Introduction
7.9.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.9.5 Johnson and Johnson Recent Development
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Details
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Introduction
7.10.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.10.5 GlaxoSmithKline Recent Development
7.11 Merck
7.11.1 Merck Company Details
7.11.2 Merck Business Overview
7.11.3 Merck Biopharmaceutical and Vaccines Introduction
7.11.4 Merck Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.11.5 Merck Recent Development
7.12 Lonza
7.12.1 Lonza Company Details
7.12.2 Lonza Business Overview
7.12.3 Lonza Biopharmaceutical and Vaccines Introduction
7.12.4 Lonza Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.12.5 Lonza Recent Development
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Company Details
7.13.2 Boehringer Ingelheim Business Overview
7.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Introduction
7.13.4 Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.13.5 Boehringer Ingelheim Recent Development
7.14 Rentschler
7.14.1 Rentschler Company Details
7.14.2 Rentschler Business Overview
7.14.3 Rentschler Biopharmaceutical and Vaccines Introduction
7.14.4 Rentschler Revenue in Biopharmaceutical and Vaccines Business (2017-2022)
7.14.5 Rentschler Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Biopharmaceutical and Vaccines Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Biopharmaceutical and Vaccines Market Trends
Table 3. Biopharmaceutical and Vaccines Market Drivers
Table 4. Biopharmaceutical and Vaccines Market Challenges
Table 5. Biopharmaceutical and Vaccines Market Restraints
Table 6. Global Biopharmaceutical and Vaccines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Biopharmaceutical and Vaccines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Biopharmaceutical and Vaccines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Biopharmaceutical and Vaccines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Biopharmaceutical and Vaccines Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Biopharmaceutical and Vaccines Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Biopharmaceutical and Vaccines Revenue Share by Player, 2017-2022
Table 13. Global Biopharmaceutical and Vaccines Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biopharmaceutical and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccines as of 2021)
Table 15. Top Players of Biopharmaceutical and Vaccines in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Biopharmaceutical and Vaccines Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Biopharmaceutical and Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Biopharmaceutical and Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Biopharmaceutical and Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Biopharmaceutical and Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Biopharmaceutical and Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Biopharmaceutical and Vaccines Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Biopharmaceutical and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Biopharmaceutical and Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Biopharmaceutical and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Biopharmaceutical and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Biopharmaceutical and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Novartis Company Details
Table 31. Novartis Business Overview
Table 32. Novartis Biopharmaceutical and Vaccines Product
Table 33. Novartis Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 34. Novartis Recent Development
Table 35. Pfizer Company Details
Table 36. Pfizer Business Overview
Table 37. Pfizer Biopharmaceutical and Vaccines Product
Table 38. Pfizer Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 39. Pfizer Recent Development
Table 40. Sanofi Company Details
Table 41. Sanofi Business Overview
Table 42. Sanofi Biopharmaceutical and Vaccines Product
Table 43. Sanofi Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 44. Sanofi Recent Development
Table 45. Roche Company Details
Table 46. Roche Business Overview
Table 47. Roche Biopharmaceutical and Vaccines Product
Table 48. Roche Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 49. Roche Recent Development
Table 50. Abbott Company Details
Table 51. Abbott Business Overview
Table 52. Abbott Biopharmaceutical and Vaccines Product
Table 53. Abbott Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Biogen Idec Company Details
Table 56. Biogen Idec Business Overview
Table 57. Biogen Idec Biopharmaceutical and Vaccines Product
Table 58. Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 59. Biogen Idec Recent Development
Table 60. Regeneron Pharmaceuticals Company Details
Table 61. Regeneron Pharmaceuticals Business Overview
Table 62. Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product
Table 63. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 64. Regeneron Pharmaceuticals Recent Development
Table 65. Alexion Pharmaceuticals Company Details
Table 66. Alexion Pharmaceuticals Business Overview
Table 67. Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product
Table 68. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 69. Alexion Pharmaceuticals Recent Development
Table 70. Johnson and Johnson Company Details
Table 71. Johnson and Johnson Business Overview
Table 72. Johnson and Johnson Biopharmaceutical and Vaccines Product
Table 73. Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 74. Johnson and Johnson Recent Development
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Biopharmaceutical and Vaccines Product
Table 78. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 79. GlaxoSmithKline Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Biopharmaceutical and Vaccines Product
Table 83. Merck Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Lonza Company Details
Table 86. Lonza Business Overview
Table 87. Lonza Biopharmaceutical and Vaccines Product
Table 88. Lonza Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 89. Lonza Recent Development
Table 90. Boehringer Ingelheim Company Details
Table 91. Boehringer Ingelheim Business Overview
Table 92. Boehringer Ingelheim Biopharmaceutical and Vaccines Product
Table 93. Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 94. Boehringer Ingelheim Recent Development
Table 95. Rentschler Company Details
Table 96. Rentschler Business Overview
Table 97. Rentschler Biopharmaceutical and Vaccines Product
Table 98. Rentschler Revenue in Biopharmaceutical and Vaccines Business (2017-2022) & (US$ Million)
Table 99. Rentschler Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharmaceutical and Vaccines Product Picture
Figure 2. Global Biopharmaceutical and Vaccines Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Biopharmaceutical and Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. United States Biopharmaceutical and Vaccines Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Biopharmaceutical and Vaccines Market Size 2017-2028 (US$ Million)
Figure 6. United States Biopharmaceutical and Vaccines Market Share in Global 2017-2028
Figure 7. Biopharmaceutical and Vaccines Report Years Considered
Figure 8. Product Picture of Biopharmaceutical
Figure 9. Product Picture of Vaccine Production
Figure 10. Global Biopharmaceutical and Vaccines Market Share by Type in 2022 & 2028
Figure 11. Global Biopharmaceutical and Vaccines Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Biopharmaceutical and Vaccines Market Share by Type (2017-2028)
Figure 13. United States Biopharmaceutical and Vaccines Market Share by Type in 2022 & 2028
Figure 14. United States Biopharmaceutical and Vaccines Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Biopharmaceutical and Vaccines Market Share by Type (2017-2028)
Figure 16. Product Picture of Pharmaceuticals Industry
Figure 17. Product Picture of Clinical Diagnosis
Figure 18. Product Picture of Scientific Research
Figure 19. Product Picture of Others
Figure 20. Global Biopharmaceutical and Vaccines Market Share by Application in 2022 & 2028
Figure 21. Global Biopharmaceutical and Vaccines Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Biopharmaceutical and Vaccines Market Share by Application (2017-2028)
Figure 23. United States Biopharmaceutical and Vaccines Market Share by Application in 2022 & 2028
Figure 24. United States Biopharmaceutical and Vaccines Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Biopharmaceutical and Vaccines Market Share by Application (2017-2028)
Figure 26. North America Biopharmaceutical and Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Biopharmaceutical and Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Biopharmaceutical and Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Biopharmaceutical and Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Biopharmaceutical and Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.A.E Biopharmaceutical and Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 55. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 56. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 57. Roche Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 58. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 59. Biogen Idec Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 60. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 61. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 62. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 65. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 66. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 67. Rentschler Revenue Growth Rate in Biopharmaceutical and Vaccines Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount